A study of 656 people with various types of blood cancers who also had COVID-19 infection found that one out of five had died between April and November, based on an analysis of data from the ASH Research Collaborative COVID-19 Registry for Hematology.
The Office of Minority Health (OMH) at the U.S. Department of Health and Human Services (HHS) announced today an approximately $1,000,000 grant to the American Society of Hematology (ASH) to develop and implement a national sickle cell disease (SCD) clinical data collection platform.
Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.
The American Society of Hematology and ASH Research Collaborative stand in unity with the Council of Medicine Specialty Societies (CMSS) and the 800,000 physicians across 45 medical specialties that deplore the negative impact of racism in our nation and of racial inequities in our healthcare system.
The ASH Research Collaborative (ASH RC) COVID-19 Registry for Hematologic Malignancy has reached the critical milestone of surpassing its first 100 clinical cases submitted.
ASH Clinical News recently covered the launch of the ASH RC Data Hub COVID-19 Registry.
The Data Hub’s Oversight Group Chair, Dr. William Wood, was recently interviewed by the ASCO Post about the ASH RC Data Hub COVID-19 Registry for Hematologic Malignancy.
The Center for Health Information Partnerships (CHIP), the ASH Research Collaborative (ASH RC), and Prometheus Research have collaborated to develop a “communicator” between two nationwide health data standards.
The ASH Research Collaborative’s Data Hub COVID-19 Registry for Hematologic Malignancy was recently covered in Healio.
A global registry for COVID-19 cases.
